Newsletter | July 10, 2024

07.10.24 -- Does The Feasibility Process Differ For Rare Diseases Vs. Common Diseases?

SPONSOR

Patient recruitment and retention is a multi-faceted, critical component of clinical trial success. Diversity, timeliness, enrollment, reimbursement, logistics, engagement – where do you start? On August 7th, hear from industry-leading suppliers ready to answer that question – and help solve your specific recruitment and retention challenges. The Clinical Leader Solutions Expo brings you its latest virtual event to help facilitate partnerships that bring life-saving therapies to patients. Register, ask questions, and find your best-fit solution for free.

DECENTRALIZED TRIALS

Post-Pandemic Planning: Direct-To-Patient Supply Chain Management

Guest Column | A conversation with Tero Laulajainen, vUCB

UCB Vice President – Head of Global Clinical Science and Operations Tero Laulajainen gets us up to speed on direct-to-patient (DTP) trials and how UCB is leveraging it today.

Can Mobile Visits Attract And Keep More Children In Clinical Trials?

Article | PCM Trials

As sponsors face regulatory pressure to include more pediatric patients in trials, could mobile nurse visits help them enroll more patients from this underrepresented group? Get the answer to this question, here.

TRIAL MANAGEMENT

Does The Feasibility Process Differ For Rare Diseases Vs. Common Diseases?

Video | Clinical Leader Live

Mimi Ermens, senior director, clinical development operations, global feasibility and start-up support, at CSL Behring answers a question from the audience about whether there is a difference in how you should approach the feasibility process when dealing with rare diseases vs. common diseases.

Unveiling The Potential Of Antibody-Drug Conjugates

Article | Novotech

Get the inside scoop on how targeted therapies are evolving through clinical trials, new uses, and groundbreaking research.

Proactive Strategies To Evaluate And Mitigate Clinical Supply Risk

Webinar | Catalent

Learn strategies for understanding risk assessment and addressing protocol requirements, drug characteristics, packaging specifications, and patient compliance concerns.

3 IRT Tactics Being Used To Streamline Supply Logistics

Article | By Maxime Schuchewytsch, IQVIA Technologies

Shipping and storing leading-edge therapeutics require complex logistics, but enhanced automation and process simplification ensure that sites and patients have the drugs they need when they need them.

Global Regulatory Excellence Throughout Clinical Development

Case Study | Veristat, Inc.

Navigating the intricate global regulatory path is crucial for clinical development success. See how expert-backed support has consistently propelled sponsors toward regulatory excellence.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: